Boston, MA, United States of America

Boris Camuzat-dedenis

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Valo Health, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Boris Camuzat-dedenis. Retrieved from https://idiyas.com/inventor/boris-camuzat-dedenis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Boris Camuzat-Dedenis: Patent Work in Pharmaceutical Chemistry.

Introduction

Boris Camuzat-Dedenis is an inventor associated with Boston, Massachusetts, and Valo Health, Inc. His patent work concerns chemical processes and compounds relevant to pharmaceutical research.

Latest Patents

The supplied information lists one patent for Camuzat-Dedenis: “Process for Preparing 6-Substituted-1-(2H)-Isoquinolinones and Intermediate Compound.” The invention describes substituted isoquinoline oxide compounds and a process for preparing them. These compounds can serve as intermediates in making 6-substituted-1-(2H)-isoquinolinones, which are described as Rho-kinase enzyme inhibitors or as intermediates for preparing further Rho-kinase inhibitors. The listed patent portfolio comprises 1 patent.

Career Highlights

Camuzat-Dedenis is associated with Valo Health, Inc. The available details highlight his contribution to a patent involving synthetic methods and intermediate compounds with potential relevance to Rho-kinase inhibitor development.

Collaborations

The supplied information identifies Par Holmberg and Sumit Kumar as Camuzat-Dedenis’s coworkers. Their shared association with Valo Health, Inc. provides context for his professional network, though no specific joint patent work is described here.

Conclusion

Boris Camuzat-Dedenis’s listed patent focuses on preparing chemical intermediates connected to 6-substituted isoquinolinones and Rho-kinase inhibitors, reflecting a contribution to pharmaceutical chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…